Golden State Equity Partners - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 117 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.

Quarter-by-quarter ownership
Golden State Equity Partners ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$568,168
+22.1%
17,9800.0%0.16%
+20.6%
Q2 2023$465,143
+7.7%
17,9800.0%0.13%
-44.0%
Q1 2023$431,880
+4.8%
17,980
-4.0%
0.23%
+13.0%
Q1 2022$412,000
+37.8%
18,7300.0%0.21%
+37.1%
Q4 2021$299,00018,7300.15%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,566,912$62,278,0004.80%
RiverVest Venture Management LLC 1,921,118$33,543,0003.68%
Burrage Capital Management LLC 161,628$2,822,0002.15%
AIGH Capital Management LLC 274,583$4,794,0001.95%
NEA Management Company, LLC 4,187,801$73,119,0001.93%
Novo Holdings A/S 2,445,147$42,692,0001.83%
Sio Capital Management, LLC 494,743$8,638,0001.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,448,912$60,218,0001.19%
Rock Springs Capital Management LP 1,496,525$26,129,0000.55%
Prosight Management, LP 60,250$1,052,0000.49%
View complete list of MIRUM PHARMACEUTICALS INC shareholders